Relapsed Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Center in Thailand.
Natsaruth SongthaweePornpun SripornsawanShevachut ChavananonEdward B McNeilThirachit ChotsampancharoenPublished in: Asian Pacific journal of cancer prevention : APJCP (2022)
The relapsed AML rate was 31% and the survival outcome was poor with a 3-year OS of 3.5%. The adverse prognostic factors were early relapse, failure to achieve CR2 and those who did not receive chemotherapy after relapse.